retatrutide type 2 diabetes trial results 2024

retatrutide type 2 diabetes trial results 2024 🚨Breaking: Retatrutide's first Phase 3 T2D data just dropped. ▸ A1C: −2.0% at 40 weeks ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No weight loss plateau — curve still descending With Sustained Type 2 Diabetes

Name: retatrutide type 2 diabetes trial results 2024 🚨Breaking: Retatrutide's first Phase 3 T2D data just dropped. ▸ A1C: −2.0% at 40 weeks ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No weight loss plateau — curve still descending With Sustained Type 2 Diabetes
Brand: www.baumstumpffraesen-lanzinger.de
SKU: 34335334266
Price: 24.85 USD
Availability: InStock
Rating: 4.446400000000001 (24 reviews)

SKU: 34335334266

4.4

EUR24.85 EUR71.85

Pay in 4 interest-free payments of $6.21 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 16 - Aug 21

Description

What the study found According to Eli Lilly, patients taking retatrutide lost nearly 30% of their body weight over 68 weeks

Ethics declarations Conflict of Interest Neil Gupta, Zaid Zayyad, Rohan Bhattaram, David Tiu, Jennifer Dau, Stephanie Dwyer Kalzuna, Vidur Gurbuxani, and Adhir R

Appetite is lower, so intake is lower, so weight falls

By this point, surgical weight loss has largely concluded

These findings suggest that the addition of GLP-1 receptor agonists to metformin therapy may mitigate certain serious adverse effects associated with metformin monotherapy